Published today in Japanese Clinical Medicine is a new original research article by Yoshiharu Wada, Yoshiyuki Hamamoto, Yukiko Kawasaki, Sachiko Honjo, Kanta Fujimoto, Hisato Tatsuoka, Atsuko Matsuoka, Hiroki Ikeda, Jun Fujikawa and Hiroyuki Koshiyama.  Read more about this paper below:

Title

The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes

Abstract

Since infection with Helicobacter pylori has been suggested to play a pathogenic role in diabetes mellitus, we investigated whether eradication therapy for H. pylori might affect glycemic control in Japanese subjects with type 2 diabetes. A total of 72 subjects (55 males, 17 females; aged 63.7 years) with type 2 diabetes who received eradication therapy for H. pylori were included. The change of their blood glycosylated hemoglobin (A1C) levels 3 months before (−3 m) the H. pylori eradication, as well as 3 months (3 m) and 6 months (6 m) after were evaluated. Their A1C levels did not show any significant change after therapy {6.9 [0.1]% (−3 m) to 7.0 [0.1]% (3 m); P = 0.3, 7.0 [0.1] (6 m); P = 0.3}. Our findings suggest that the eradication therapy for H. pylori does not, at least profoundly, affect glycemic control in Japanese subjects with type 2 diabetes.

Click here to learn more about the article, download it and comment

share on